Takeaway

• The final results of the TOTEM study show that intensive follow-up in patients treated for endometrial cancer does not improve overall survival, even in high-risk patients.
• There was also no difference in relapse-free survival (RFS), health-related quality of life (HRQoL) or compliance.

Why this matters

• Intensive follow-up in cancer care...